Clinical trial
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
NCT00902369 is registered in ClinicalTrials.gov with Asahi Kasei Therapeutics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
- Lead sponsor
- Asahi Kasei Therapeutics Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- July 31, 2010
- Enrollment
- 130 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis